SOX21 and glioblastoma: In order to evaluate the performance of HMG-related genes as markers, we obtained two gene markers (SOX21, HR: 0.970 (95% CI: 0.942–0.999)); SOX6, HR: 0.906 (95%) to predict the prognosis of GBM patients through forest distribution maps.